Acadian Asset Management
LMAT icon

Acadian Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Acadian Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
1,114
-3,118
-74% -$320K ﹤0.01% 1745
2026
Q1 		$461K Sell
4,232
-11,282
-73% -$1.08M ﹤0.01% 1378
2025
Q4 		$1.25M Buy
15,514
+5,048
+48% +$435K ﹤0.01% 1041
2025
Q3 		$913K Buy
+10,466
New +$935K ﹤0.01% 1079
2024
Q4 		– Sell
-4,279
Closed -$396K – 1931
2024
Q3 		$396K Buy
4,279
+3,007
+236% +$261K ﹤0.01% 1141
2024
Q2 		$104K Buy
+1,272
New +$93.4K ﹤0.01% 1532
2021
Q4 		– Sell
-3,503
Closed -$185K – 1777
2021
Q3 		$185K Sell
3,503
-5,185
-60% -$292K ﹤0.01% 1314
2021
Q2 		$529K Buy
8,688
+3,946
+83% +$210K ﹤0.01% 1136
2021
Q1 		$231K Buy
+4,742
New +$222K ﹤0.01% 1449
2020
Q3 		– Sell
-1,539
Closed -$41K – 2275
2020
Q2 		$41K Sell
1,539
-167
-10% -$4.37K ﹤0.01% 1969
2020
Q1 		$42K Sell
1,706
-17,516
-91% -$541K ﹤0.01% 1538
2019
Q4 		$691K Buy
19,222
+7,958
+71% +$275K ﹤0.01% 985
2019
Q3 		$385K Buy
+11,264
New +$360K ﹤0.01% 1161
2018
Q4 		– Sell
-1,999
Closed -$77K – 1776
2018
Q3 		$77K Buy
1,999
+40
+2% +$1.44K ﹤0.01% 1272
2018
Q2 		$66K Buy
+1,959
New +$69.7K ﹤0.01% 1341
2018
Q1 		– Sell
-24,865
Closed -$792K – 1758
2017
Q4 		$792K Sell
24,865
-20,365
-45% -$698K ﹤0.01% 731
2017
Q3 		$1.69M Buy
45,230
+43,346
+2,301% +$1.48M 0.01% 599
2017
Q2 		$59K Sell
1,884
-34,750
-95% -$1M ﹤0.01% 1104
2017
Q1 		$902K Sell
36,634
-33,961
-48% -$797K ﹤0.01% 780
2016
Q4 		$1.79M Sell
70,595
-15,386
-18% -$341K 0.01% 614
2016
Q3 		$1.71M Sell
85,981
-56,935
-40% -$995K 0.01% 586
2016
Q2 		$2.04M Sell
142,916
-41,329
-22% -$632K 0.01% 519
2016
Q1 		$2.86M Buy
184,245
+56,631
+44% +$812K 0.01% 485
2015
Q4 		$2.2M Buy
127,614
+47,581
+59% +$689K 0.01% 556
2015
Q3 		$975K Buy
+80,033
New +$1.03M 0.01% 680

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Acadian Asset Management's LMAT Position: Q2 2026 in Review

Acadian Asset Management reduced its LeMaitre Vascular (LMAT) stake by 74% in Q2 2026, selling an estimated $320K and leaving 1,114 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Acadian Asset Management first reported a position in LMAT in Q3 2015 and has held it in 25 quarters since. The position peaked at $2.86M in Q1 2016. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Acadian Asset Management held 1,114 shares of LeMaitre Vascular worth $106K as of Q2 2026.
  • Acadian Asset Management sold 3,118 LeMaitre Vascular shares in Q2 2026, an estimated $320K.
  • LeMaitre Vascular made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1745 holding.
  • Acadian Asset Management first reported a position in LeMaitre Vascular in Q3 2015 and has held it in 25 quarters since.
  • Acadian Asset Management's LeMaitre Vascular position peaked at $2.86M in Q1 2016.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.